Literature DB >> 20920827

Reversal of retinal ganglion cell dysfunction after surgical reduction of intraocular pressure.

Mitra Sehi1, Dilraj S Grewal, Margot L Goodkin, David S Greenfield.   

Abstract

PURPOSE: The pattern electroretinogram optimized for glaucoma screening (PERGLA) is a noninvasive method of objectively measuring retinal ganglion cell (RGC) function. This study was undertaken to quantify the RGC response to intraocular pressure (IOP) reduction after glaucoma surgery.
DESIGN: Prospective cohort study. PARTICIPANTS: Forty-seven eyes of 47 patients with uncontrolled IOP or progressive glaucomatous optic neuropathy receiving maximal medical therapy requiring trabeculectomy or aqueous drainage device implantation who met eligibility criteria.
METHODS: Eyes with visual acuity less than 20/30, corneal or retinal pathologic features, or unreliable standard automated perimetry (SAP) results were excluded. All patients underwent complete ocular examination, arterial blood pressure, SAP, and PERGLA at 2 sessions before surgery and at 3 months after surgery. Mean ocular perfusion pressure (MOPP) was calculated. Each measure of PERGLA amplitude and phase was an average of 600 artifact-free signal registrations. MAIN OUTCOME MEASURES: Intraocular pressure and PERGLA amplitude and phase.
RESULTS: Forty-seven eyes of 47 patients (mean age ± standard deviation [SD], 69.9 ± 11.3 years) were enrolled. Thirty-four eyes (72%) underwent trabeculectomy with antifibrosis therapy; 13 eyes (28%) underwent glaucoma drainage implant surgery. Mean ± SD postoperative IOP (10.4 ± 4.6 mmHg) was significantly (P< 0.001) reduced compared with that before surgery (19.7 ± 8.6 mmHg). Mean ± SD postoperative PERGLA amplitude (0.46 ± 0.22 μV) was significantly (P = 0.001) increased compared with preoperative PERGLA amplitude (0.37 ± 0.18 μV). Mean ± SD postoperative PERGLA phase (1.72 ± 0.20 π-radian) was significantly (P = 0.01) reduced compared with preoperative PERGLA phase (1.81 ± 0.22 π-radian). Mean ± SD postoperative MOPP (53.1 ± 6.4 mmHg) was significantly (P < 0.001) increased compared with mean ± SD preoperative MOPP (45.8 ± 10.1 mmHg). No correlation (P > 0.05) was identified between change in PERGLA amplitude and change in IOP or MOPP.
CONCLUSIONS: Reversal of RGC dysfunction occurs after surgical reduction of IOP and may be quantified using PERGLA.
Copyright © 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20920827     DOI: 10.1016/j.ophtha.2010.08.049

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  31 in total

1.  Progressive loss of retinal ganglion cell function is hindered with IOP-lowering treatment in early glaucoma.

Authors:  Lori M Ventura; William J Feuer; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-13       Impact factor: 4.799

2.  Head-down posture induces PERG alterations in early glaucoma.

Authors:  Lori M Ventura; Iuri Golubev; William Lee; Izuru Nose; Jean-Marie Parel; William J Feuer; Vittorio Porciatti
Journal:  J Glaucoma       Date:  2013-03       Impact factor: 2.503

Review 3.  The challenge of regenerative therapies for the optic nerve in glaucoma.

Authors:  David J Calkins; Milos Pekny; Melissa L Cooper; Larry Benowitz
Journal:  Exp Eye Res       Date:  2017-01-30       Impact factor: 3.467

4.  Pattern electroretinogram to detect glaucoma: comparing the PERGLA and the PERG Ratio protocols.

Authors:  Michael Bach; Anke Ramharter-Sereinig
Journal:  Doc Ophthalmol       Date:  2013-10-15       Impact factor: 2.379

Review 5.  Targeting retinal ganglion cell recovery.

Authors:  J G Crowston; E T Fahy; L Fry; I A Trounce; P van Wijngaarden; S Petrou; V Chrysostomou
Journal:  Eye (Lond)       Date:  2017-01-06       Impact factor: 3.775

Review 6.  Critical pathogenic events underlying progression of neurodegeneration in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2012-08-01       Impact factor: 21.198

7.  Ganglion cell loss in early glaucoma, as assessed by photopic negative response, pattern electroretinogram, and spectral-domain optical coherence tomography.

Authors:  Barbara Cvenkel; Maja Sustar; Darko Perovšek
Journal:  Doc Ophthalmol       Date:  2017-05-31       Impact factor: 2.379

8.  Adaptation of the steady-state PERG in early glaucoma.

Authors:  Vittorio Porciatti; Brandon Bosse; Prashant K Parekh; Olga A Shif; William J Feuer; Lori M Ventura
Journal:  J Glaucoma       Date:  2014 Oct-Nov       Impact factor: 2.503

9.  A new mouse model of inducible, chronic retinal ganglion cell dysfunction not associated with cell death.

Authors:  Xu Yang; Tsung-Han Chou; Marco Ruggeri; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-28       Impact factor: 4.799

10.  Pattern ERG and RNFL thickness in hypertensive eyes with normal blue-yellow visual field.

Authors:  Maurizio G Uva; Massimo Di Pietro; Antonio Longo; Katia Lauretta; Michele Reibaldi; Alfredo Reibaldi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.